SREBF1 and Insulin resistance: So all serum parameters indicate that the alb-SREBP–1aΔP mice are protected of the fatty liver phenotype compared to the alb-SREBP–1a mice, which develop fatty liver, obesity, hypertriglyeridemia, and insulin resistance.